SAPHRIS (Organon Pharmaceuticals USA)


Welcome to the PulseAid listing for the SAPHRIS drug offered from Organon Pharmaceuticals USA. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Organon Pharmaceuticals USA
NON-PROPRIETARY NAME: Asenapine Maleate
SUBSTANCE NAME: ASENAPINE MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: SUBLINGUAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-13
END MARKETING DATE: 0000-00-00


SAPHRIS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSAPHRIS from Organon Pharmaceuticals USA
LABELER NAME: Organon Pharmaceuticals USA
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2009-08-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0052-0118_da55e2fe-c473-46cc-a4b4-d31c8e63d148
PRODUCT NDC: 0052-0118
APPLICATION NUMBER: NDA022117

Other ASENAPINE MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan USA, Inc.SAPHRIS
Organon Pharmaceuticals USASAPHRIS
STAT RX USA LLCSAPHRIS